DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)

70.12 0.77 (1.11%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AZN $70.12 1.11%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $69.21
Previous Close $69.35
Daily Range $69.17 - $70.32
52-Week Range $51.98 - $82.68
Market Cap $88.5B
P/E Ratio 34.00
Dividend (Yield) $1.80 (4.0%)
Ex-Dividend Date
Dividend Pay Date
08/13/14
09/15/14
Volume 2,346,479
Average Daily Volume 2,332,020
Current FY EPS $4.45

Sector

Healthcare

Industry

Drugs

AstraZeneca plc (ADR) (AZN) Description

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Website: http://www.astrazeneca.com/

News & Commentary

Bristol-Myers Squibb Co's Third-Quarter Earnings Beat the Street

Bristol-Myers Squibb reported third-quarter earnings this morning. Here's what you need to know.

Bristol-Myers Beats on Q3 Earnings, Maintains Guidance - Analyst Blog

What to look for in Pfizer earnings

Pfizer (PFE) $11B Stock Repurchase Plan May End AstraZeneca (AZN) Bid

Today's Market: News And Earnings Fueling These Moves

In the news: Pfizer's giant repurchase and lots more earnings

In teh news: Pfizer's giant repurchase and lots more earnings

October 24 Premarket Briefing: 10 Things You Should Know

Novartis' Secukinumab Receives Favorable FDA Panel Vote - Analyst Blog

3 Beaten Down Biotech Stocks to Buy Now

The share prices of Dynavax Technologies, CellDex Therapeutics, and Clovis Oncology have all plunged this year. Here is why I think these beaten down biotechs are now compelling buys.

See More AZN News...

AZN's Top Competitors

AZN $70.12 (1.11%)
Current stock: AZN
JNJ $103.13 (0.49%)
Current stock: JNJ
PFE $29.11 (1.78%)
Current stock: PFE
RHHBY $36.58 (-0.19%)
Current stock: RHHBY